Solara Active Pharma Sciences Ltd.

View in App
356.55 -1.30 ▼-0.4%

21 September 2023, 04:01:00 PM
Volume: 5,719

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.solara.co.in
Market Cap 1,283.45 Cr.
Enterprise Value(EV) 2,275.71 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) -7.03 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-06
Industry PE 37.95 Trailing Twelve Months Ending 2023-06
Book Value / Share 411.17 Trailing Twelve Months Ending 2023-06
Price to Book Value 0.87 Calculated using Price: 356.55
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 3.60 Cr. 35,996,267 Shares
FaceValue 10
About Solara Active Pharma Sciences Ltd.
Solara Active Pharma Sciences is a dynamic, entrepreneurial and customer-oriented API manufacturer. It has a legacy of over three decades and trace its origins to the API expertise of Strides Shasun Ltd. and the technical know-how of human API business from Sequent Scientific Ltd. The company is a global, R&D focused, pureplay API company engaged in the manufacturing and development of APIs and offering Contract Manufacturing and Development Services for global companies.

Solara Active Pharma Sciences Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Solara Active Pharma Sciences Ltd. Performance

View details >>
1 Day
-0.36%
1 Week
-2.44%
1 Month
+1.35%
3 Month
-3.45%
6 Month
-1.29%
1 Year
-21.42%
2 Year
-78.43%
5 Year
+24.95%
10 Year

Solara Active Pharma Sciences Ltd. Fundamental Ratios

View details >>
6 years 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 0.04 7.36 12.48 17.23 -3.75 -1.47
Return on Capital Employed (%) 1.82 9.70 11.73 15.34 -0.67 1.79
Return on Assets (%) 0.02 3.14 5.57 9.34 -2.13 -0.78

Solara Active Pharma Sciences Ltd. Balance Sheet

View details >>
Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 764 956 1,086 1,589 1,525 1,500
Non Curr. Liab. 315 344 333 206 299 217
Curr. Liab. 738 656 730 789 1,063 1,101
Minority Int. 4 4 4 4 2 2
Equity & Liab. 1,821 1,960 2,153 2,588 2,890 2,821
Non Curr. Assets 1,214 1,312 1,481 1,530 1,651 1,633
Curr. Assets 608 648 672 1,058 1,239 1,188
Misc. Exp. not W/O
Total Assets 1,821 1,960 2,153 2,588 2,890 2,821

Solara Active Pharma Sciences Ltd. Profit and Loss

View details >>
Particulars 7 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 560 1,409 1,322 1,617 1,268 1,444 1,466
Other Income 2 12 28 29 20 23 18
Total Income 563 1,421 1,349 1,646 1,288 1,466 1,484
Total Expenditure -501 -1,197 -1,062 -1,231 -1,188 -1,310 -1,326
PBIDT 62 224 287 415 100 156 158
Interest -25 -82 -78 -84 -75 -90 -92
Depreciation -37 -84 -94 -109 -112 -111 -109
Taxation 0 2 0 0 33 23 18
Exceptional Items -3
PAT 0 59 115 221 -58 -22 -25
Minority Interest 0 0 0 0 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 0 60 115 221 -58 -22 -25
Adjusted EPS 0 23 43 62 -16 -6 -7

Solara Active Pharma Sciences Ltd. Cash Flow

View details >>
Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 49 166 242 155 -242 156
Cash Fr. Inv. -85 -116 -359 -106 -243 -81
Cash Fr. Finan. 68 -23 97 92 334 -113
Net Change 31 27 -20 142 -151 -38
Cash & Cash Eqvt 46 76 56 198 46 9

Solara Active Pharma Sciences Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 41.07 41.07 39.51 39.71 40.40 40.40 40.40 40.97 39.31
Public 58.93 58.93 60.49 60.29 59.60 59.60 59.60 59.03 60.69
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 8.86 13.55 29.44 27.51 27.98 28.18 33.73 40.46 39.79

Solara Active Pharma Sciences Ltd. Announcements

View details >>
Mon, 18 Sep 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation pursuant to Regulation 39(3) of SEBI (LODR) Regulations 2015.
Sun, 17 Sep 2023
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Submission of Voting Results of the Sixth Annual General Meeting (AGM) pursuant to Regulation 44 of SEBI (LODR) Regulations 2015. We also enclose the Consolidated Scrutinizers Report on remote e-voting and by e-voting at the AGM.
Fri, 15 Sep 2023
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 6th Annual General Meeting (AGM) of the Company.

Solara Active Pharma Sciences Ltd. Technical Scans

View details >>
Thu, 21 Sep 2023
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Making Lower Lows for 2 Days Making Lower Lows for 2 Days
High Decrease in 2 Years High Decrease in 2 Years
CCI Oversold Zone CCI Oversold Zone

Solara Active Pharma Sciences Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 274,963.79 1,148.50 -0.4%
Divi's Laboratories Ltd. 99,404.71 3,741.45 -1.0%
Cipla Ltd. 97,455.33 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. 94,594.48 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. 72,171.99 5,023.50 +0.4%
Mankind Pharma Ltd. 69,708.40 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. 63,451.75 1,874.80 -0.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.67 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-06 67.23 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-06 31.32 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 20.07 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 108.04 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 54.38 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 50.36 1,874.80 -0.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.75 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-06 7.57 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-06 4.00 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.86 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.52 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 5.69 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.65 1,874.80 -0.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-03 0.02 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,874.80 -0.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,874.80 -0.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,874.80 -0.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,874.80 -0.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,874.80 -0.5%

Solara Active Pharma Sciences Ltd. FAQ's

What is Solara Active Pharma share price?
Can I buy Solara Active Pharma shares now?
What is the Market Cap of Solara Active Pharma?
What are the key metrics to analyse Solara Active Pharma?
What is the 52 Week High and Low of Solara Active Pharma?
What is the trend of Solara Active Pharma share price?